Based in Austin, TX, Triumvira Immunologics is a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers.

Teresa McRoberts brings more than four decades of experience in the financial sector across both the buy-side and sell-side with a focus on healthcare. Prior to joining Triumvira, she was Portfolio Manager, Senior Vice President and Senior Analyst at Alger Management, a growth-style investment management company, where she grew Alger’s Health Sciences Trust into a top 10% healthcare mutual fund. She was also previously Portfolio Manager at Morgan Stanley, Portfolio Co-Manager at Tribeca Global Management, a hedge fund owned by Citigroup, and an analyst and investment banker with J.P. Morgan. Ms. McRoberts holds a Master of Business Administration from Columbia Business School and Bachelor of Arts in English from Oberlin College.